+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Dengue Vaccine Market Size, Share & Trends Analysis Report by Product (Dengvaxia, Qdenga), End-user (Government & Public Health Agencies, Hospitals & Specialty Clinics), and Region with Growth Forecasts, 2025-2033

  • PDF Icon

    Report

  • 150 Pages
  • September 2025
  • Region: Global
  • Grand View Research
  • ID: 6176701
REQUEST CUSTOMIZATION
Description Jump to:
The global dengue vaccine market size was estimated at USD 578.48 Million in 2025 and is projected to reach USD 1.61 billion by 2033, growing at a CAGR of 13.73% from 2025 to 2033. The increasing prevalence of dengue fever across tropical and subtropical regions drives strong demand for effective vaccines.

The increasing urbanization and population density create favorable conditions for Aedes mosquitoes, the primary carriers of the virus. The increasing frequency of outbreaks highlights urgent preventive needs, as seen in April 2025, when the World Stock Market reported Brazil had registered 1,010,833 probable cases, 668 confirmed deaths, and 724 under investigation, with São Paulo leading at 585,902 cases. The incidence rate was 475.5 per 100,000, lower than 1,881 per 100,000 in 2024. The increasing awareness among healthcare providers and patients, combined with advances in research, greater accessibility in clinics, and stronger pharmaceutical collaborations, accelerates vaccine adoption and supports global dengue control efforts.

In July 2025, KFF Health News reported a sharp rise in dengue cases across the contiguous United States. The number of new infections reached approximately 3,700, nearly doubling from about 2,050 cases in 2023. Of these, 105 cases were confirmed to be locally transmitted in California, Florida, and Texas, signaling a concerning trend in domestic spread. Historically, dengue infections in the U.S. were mostly travel-related, but the rising local transmission indicates that the Aedes aegypti mosquito has expanded its presence. This surge reflects changing environmental conditions and highlights growing risks for communities that previously faced minimal exposure to dengue. The sudden escalation of cases underscores an urgent need for preventive strategies, including vaccination, mosquito control, and improved monitoring.

Global Dengue Vaccine Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, the analyst has segmented the global dengue vaccine market report based on product, end-user, and region:

Product Outlook (Revenue, USD Million, 2021-2033)

  • Dengvaxia
  • Qdenga
  • Others

End-user Outlook (Revenue, USD Million, 2021-2033)

  • Government & Public Health Agencies
  • Hospitals & Specialty Clinics
  • Others

Regional Outlook (Revenue, USD Million, 2021-2033)

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East & Africa

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segmental and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listings for you to stay ahead of the curve

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Product
1.2.2. End User
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. Internal Database
1.5.3. Secondary Sources
1.5.4. Primary Research
1.6. Information Analysis
1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Dengue Vaccine Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Business Environment Analysis
3.3.1. Industry Analysis - Porter’s Five Forces Analysis
3.3.1.1. Supplier Power
3.3.1.2. Buyer Power
3.3.1.3. Substitution Threat
3.3.1.4. Threat of New Entrants
3.3.1.5. Competitive Rivalry
3.3.2. PESTLE Analysis
3.3.3. Pipeline Analysis
3.3.4. Patent Expiry Analysis
3.3.5. Pricing Analysis
Chapter 4. Dengue Vaccine Market: Product Business Analysis
4.1. Product Market Share, 2024 & 2033
4.2. Product Segment Dashboard
4.3. Market Size & Forecasts and Trend Analysis, by Product, 2021 to 2033 (USD Million)
4.4. Dengvaxia
4.4.1. Dengvaxia Market, 2021-2033 (USD Million)
4.5. Qdenga
4.5.1. Qdenga Market, 2021-2033 (USD Million)
4.6. Others
4.6.1. Others Market, 2021-2033 (USD Million)
Chapter 5. Dengue Vaccine Market: End User Business Analysis
5.1. End User Market Share, 2024 & 2033
5.2. End User Segment Dashboard
5.3. Market Size & Forecasts and Trend Analysis, by End User, 2021 to 2033 (USD Million)
5.4. Government & Public Health Agencies
5.4.1. Government & Public Health Agencies Market, 2021-2033 (USD Million)
5.5. Hospitals & Specialty Clinics
5.5.1. Hospitals & Specialty Clinics Market, 2021-2033 (USD Million)
5.6. Others
5.6.1. Others Market, 2021-2033 (USD Million)
Chapter 6. Dengue Vaccine Market: Regional Estimates & Trend Analysis
6.1. Regional Market Share Analysis, 2024 & 2033
6.2. Regional Market Dashboard
6.3. Market Size & Forecasts Trend Analysis, 2021 to 2033:
6.4. North America
6.4.1. North America Dengue Vaccine Market Estimates and Forecasts, by Country, 2021-2033 (USD Million)
6.4.2. U.S.
6.4.2.1. Key Country Dynamics
6.4.2.2. Target Disease Prevalence
6.4.2.3. Regulatory Framework
6.4.2.4. Reimbursement Framework
6.4.2.5. U.S. Dengue Vaccine Market Estimates and Forecasts, 2021-2033 (USD Million)
6.4.3. Canada
6.4.3.1. Key Country Dynamics
6.4.3.2. Target Disease Prevalence
6.4.3.3. Regulatory Framework
6.4.3.4. Reimbursement Framework
6.4.3.5. U.S. Dengue Vaccine Market Estimates and Forecasts, 2021-2033 (USD Million)
6.4.4. Mexico
6.4.4.1. Key Country Dynamics
6.4.4.2. Target Disease Prevalence
6.4.4.3. Regulatory Framework
6.4.4.4. Reimbursement Framework
6.4.4.5. Mexico Dengue Vaccine Market Estimates and Forecasts, 2021-2033 (USD Million)
6.5. Europe
6.5.1. Europe Dengue Vaccine Market Estimates and Forecasts, 2021-2033 (USD Million)
6.5.2. UK
6.5.2.1. Key Country Dynamics
6.5.2.2. Target Disease Prevalence
6.5.2.3. Regulatory Framework
6.5.2.4. Reimbursement Framework
6.5.2.5. Uk Dengue Vaccine Market Estimates and Forecasts, 2021-2033 (USD Million)
6.5.3. Germany
6.5.3.1. Key Country Dynamics
6.5.3.2. Target Disease Prevalence
6.5.3.3. Regulatory Framework
6.5.3.4. Reimbursement Framework
6.5.3.5. Germany Dengue Vaccine Market Estimates and Forecasts, 2021-2033 (USD Million)
6.5.4. France
6.5.4.1. Key Country Dynamics
6.5.4.2. Target Disease Prevalence
6.5.4.3. Regulatory Framework
6.5.4.4. Reimbursement Framework
6.5.4.5. France Dengue Vaccine Market Estimates and Forecasts, 2021-2033 (USD Million)
6.5.5. Italy
6.5.5.1. Key Country Dynamics
6.5.5.2. Target Disease Prevalence
6.5.5.3. Regulatory Framework
6.5.5.4. Reimbursement Framework
6.5.5.5. Italy Dengue Vaccine Market Estimates and Forecasts, 2021-2033 (USD Million)
6.5.6. Spain
6.5.6.1. Key Country Dynamics
6.5.6.2. Target Disease Prevalence
6.5.6.3. Regulatory Framework
6.5.6.4. Reimbursement Framework
6.5.6.5. Spain Dengue Vaccine Market Estimates and Forecasts, 2021-2033 (USD Million)
6.5.7. Denmark
6.5.7.1. Key Country Dynamics
6.5.7.2. Target Disease Prevalence
6.5.7.3. Regulatory Framework
6.5.7.4. Reimbursement Framework
6.5.7.5. Denmark Dengue Vaccine Market Estimates and Forecasts, 2021-2033 (USD Million)
6.5.8. Sweden
6.5.8.1. Key Country Dynamics
6.5.8.2. Target Disease Prevalence
6.5.8.3. Regulatory Framework
6.5.8.4. Reimbursement Framework
6.5.8.5. Sweden Dengue Vaccine Market Estimates and Forecasts, 2021-2033 (USD Million)
6.5.9. Norway
6.5.9.1. Key Country Dynamics
6.5.9.2. Target Disease Prevalence
6.5.9.3. Regulatory Framework
6.5.9.4. Reimbursement Framework
6.5.9.5. Norway Dengue Vaccine Market Estimates and Forecasts, 2021-2033 (USD Million)
6.6. Asia-Pacific
6.6.1. Asia-Pacific Dengue Vaccine Market Estimates and Forecasts, 2021-2033 (USD Million)
6.6.2. Japan
6.6.2.1. Key Country Dynamics
6.6.2.2. Target Disease Prevalence
6.6.2.3. Regulatory Framework
6.6.2.4. Reimbursement Framework
6.6.2.5. Japan Dengue Vaccine Market Estimates and Forecasts, 2021-2033 (USD Million)
6.6.3. China
6.6.3.1. Key Country Dynamics
6.6.3.2. Target Disease Prevalence
6.6.3.3. Regulatory Framework
6.6.3.4. Reimbursement Framework
6.6.3.5. China Dengue Vaccine Market Estimates and Forecasts, 2021-2033 (USD Million)
6.6.4. India
6.6.4.1. Key Country Dynamics
6.6.4.2. Target Disease Prevalence
6.6.4.3. Regulatory Framework
6.6.4.4. Reimbursement Framework
6.6.4.5. India Dengue Vaccine Market Estimates and Forecasts, 2021-2033 (USD Million)
6.6.5. Australia
6.6.5.1. Key Country Dynamics
6.6.5.2. Target Disease Prevalence
6.6.5.3. Regulatory Framework
6.6.5.4. Reimbursement Framework
6.6.5.5. Australia Dengue Vaccine Market Estimates and Forecasts, 2021-2033 (USD Million)
6.6.6. South Korea
6.6.6.1. Key Country Dynamics
6.6.6.2. Target Disease Prevalence
6.6.6.3. Regulatory Framework
6.6.6.4. Reimbursement Framework
6.6.6.5. South Korea Dengue Vaccine Market Estimates and Forecasts, 2021-2033 (USD Million)
6.6.7. Thailand
6.6.7.1. Key Country Dynamics
6.6.7.2. Target Disease Prevalence
6.6.7.3. Regulatory Framework
6.6.7.4. Reimbursement Framework
6.6.7.5. Thailand Dengue Vaccine Market Estimates and Forecasts, 2021-2033 (USD Million)
6.7. Latin America
6.7.1. Latin America Dengue Vaccine Market Estimates and Forecasts, 2021-2033 (USD Million)
6.7.2. Brazil
6.7.2.1. Key Country Dynamics
6.7.2.2. Target Disease Prevalence
6.7.2.3. Regulatory Framework
6.7.2.4. Reimbursement Framework
6.7.2.5. Japan Dengue Vaccine Market Estimates and Forecasts, 2021-2033 (USD Million)
6.7.3. Argentina
6.7.3.1. Key Country Dynamics
6.7.3.2. Target Disease Prevalence
6.7.3.3. Regulatory Framework
6.7.3.4. Reimbursement Framework
6.7.3.5. China Dengue Vaccine Market Estimates and Forecasts, 2021-2033 (USD Million)
6.8. Middle East and Africa
6.8.1. Middle East and Africa Dengue Vaccine Market Estimates and Forecasts, 2021-2033 (USD Million)
6.8.2. South Africa
6.8.2.1. Key Country Dynamics
6.8.2.2. Target Disease Prevalence
6.8.2.3. Regulatory Framework
6.8.2.4. Reimbursement Framework
6.8.2.5. South Africa Dengue Vaccine Market Estimates and Forecasts, 2021-2033 (USD Million)
6.8.3. Saudi Arabia
6.8.3.1. Key Country Dynamics
6.8.3.2. Target Disease Prevalence
6.8.3.3. Regulatory Framework
6.8.3.4. Reimbursement Framework
6.8.3.5. Saudi Arabia Dengue Vaccine Market Estimates and Forecasts, 2021-2033 (USD Million)
6.8.4. UAE
6.8.4.1. Key Country Dynamics
6.8.4.2. Target Disease Prevalence
6.8.4.3. Regulatory Framework
6.8.4.4. Reimbursement Framework
6.8.4.5. UAE Dengue Vaccine Market Estimates and Forecasts, 2021-2033 (USD Million)
6.8.5. Kuwait
6.8.5.1. Key Country Dynamics
6.8.5.2. Target Disease Prevalence
6.8.5.3. Regulatory Framework
6.8.5.4. Reimbursement Framework
6.8.5.5. Kuwait Dengue Vaccine Market Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 7. Competitive Landscape
7.1. Participant Overview
7.2. Company Market Position Analysis
7.3. Company Categorization
7.4. Strategy Mapping
7.5. Company Profiles/Listing
7.5.1. Sanofi
7.5.1.1. Overview
7.5.1.2. Financial Performance
7.5.1.3. Product Benchmarking
7.5.1.4. Strategic Initiatives
7.5.2. Takeda Pharmaceutical Company Limited
7.5.2.1. Overview
7.5.2.2. Financial Performance
7.5.2.3. Product Benchmarking
7.5.2.4. Strategic Initiatives
List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Global dengue vaccine market, by region, 2021-2033 (USD Million)
Table 4 Global dengue vaccine market, by product, 2021-2033 (USD Million)
Table 5 Global dengue vaccine market, by end user, 2021-2033 (USD Million)
Table 6 North America dengue vaccine market, by country, 2021-2033 (USD Million)
Table 7 North America dengue vaccine market, by product, 2021-2033 (USD Million)
Table 8 North America dengue vaccine market, by end user, 2021-2033 (USD Million)
Table 9 U.S. dengue vaccine market, by product, 2021-2033 (USD Million)
Table 10 U.S. dengue vaccine market, by end user, 2021-2033 (USD Million)
Table 11 Canada dengue vaccine market, by product, 2021-2033 (USD Million)
Table 12 Canada dengue vaccine market, by end user, 2021-2033 (USD Million)
Table 13 Mexico dengue vaccine market, by product, 2021-2033 (USD Million)
Table 14 Mexico dengue vaccine market, by end user, 2021-2033 (USD Million)
Table 15 Europe dengue vaccine market, by country, 2021-2033 (USD Million)
Table 16 Europe dengue vaccine market, by product, 2021-2033 (USD Million)
Table 17 Europe dengue vaccine market, by end user, 2021-2033 (USD Million)
Table 18 UK dengue vaccine market, by product, 2021-2033 (USD Million)
Table 19 UK dengue vaccine market, by end user, 2021-2033 (USD Million)
Table 20 Germany dengue vaccine market, by product, 2021-2033 (USD Million)
Table 21 Germany dengue vaccine market, by end user, 2021-2033 (USD Million)
Table 22 France dengue vaccine market, by product, 2021-2033 (USD Million)
Table 23 France dengue vaccine market, by end user, 2021-2033 (USD Million)
Table 24 Italy dengue vaccine market, by product, 2021-2033 (USD Million)
Table 25 Italy dengue vaccine market, by end user, 2021-2033 (USD Million)
Table 26 Spain dengue vaccine market, by product, 2021-2033 (USD Million)
Table 27 Spain dengue vaccine market, by end user, 2021-2033 (USD Million)
Table 28 Norway dengue vaccine market, by product, 2021-2033 (USD Million)
Table 29 Norway dengue vaccine market, by end user, 2021-2033 (USD Million)
Table 30 Denmark dengue vaccine market, by product, 2021-2033 (USD Million)
Table 31 Denmark dengue vaccine market, by end user, 2021-2033 (USD Million)
Table 32 Sweden dengue vaccine market, by product, 2021-2033 (USD Million)
Table 33 Sweden dengue vaccine market, by end user, 2021-2033 (USD Million)
Table 34 Asia-Pacific dengue vaccine market, by country, 2021-2033 (USD Million)
Table 35 Asia-Pacific dengue vaccine market, by product, 2021-2033 (USD Million)
Table 36 Asia-Pacific dengue vaccine market, by end user, 2021-2033 (USD
Table 37 Million)
Table 38 Japan dengue vaccine market, by product, 2021-2033 (USD Million)
Table 39 Japan dengue vaccine market, by end user, 2021-2033 (USD Million)
Table 40 China dengue vaccine market, by product, 2021-2033 (USD Million)
Table 41 China dengue vaccine market, by end user, 2021-2033 (USD Million)
Table 42 India dengue vaccine market, by product, 2021-2033 (USD Million)
Table 43 India dengue vaccine market, by end user, 2021-2033 (USD Million)
Table 44 Australia dengue vaccine market, by product, 2021-2033 (USD Million)
Table 45 Australia dengue vaccine market, by end user, 2021-2033 (USD Million)
Table 46 South Korea dengue vaccine market, by product, 2021-2033 (USD Million)
Table 47 South Korea dengue vaccine market, by end user, 2021-2033 (USD Million)
Table 48 Thailand dengue vaccine market, by product, 2021-2033 (USD Million)
Table 49 Thailand dengue vaccine market, by end user, 2021-2033 (USD Million)
Table 50 Latin America dengue vaccine market, by country, 2021-2033 (USD Million)
Table 51 Latin America dengue vaccine market, by product, 2021-2033 (USD Million)
Table 52 Latin America dengue vaccine market, by end user, 2021-2033 (USD Million)
Table 53 Brazil dengue vaccine market, by product, 2021-2033 (USD Million)
Table 54 Brazil dengue vaccine market, by end user, 2021-2033 (USD Million)
Table 55 Argentina dengue vaccine market, by product, 2021-2033 (USD Million)
Table 56 Argentina dengue vaccine market, by end user, 2021-2033 (USD Million)
Table 57 Middle East & Africa Dengue vaccine market, by country, 2021-2033 (USD Million)
Table 58 Middle East & Africa dengue vaccine market, by product, 2021-2033 (USD Million)
Table 59 Middle East & Africa dengue vaccine market, by end user, 2021-2033 (USD Million)
Table 60 South Africa dengue vaccine market, by product, 2021-2033 (USD Million)
Table 61 South Africa dengue vaccine market, by end user, 2021-2033 (USD Million)
Table 62 Saudi Arabia dengue vaccine market, by product, 2021-2033 (USD Million)
Table 63 Saudi Arabia dengue vaccine market, by end user, 2021-2033 (USD Million)
Table 64 UAE dengue vaccine market, by product, 2021-2033 (USD Million)
Table 65 UAE dengue vaccine market, by end user, 2021-2033 (USD Million)
Table 66 Kuwait dengue vaccine market, by product, 2021-2033 (USD Million)
Table 67 Kuwait dengue vaccine market, by end user, 2021-2033 (USD Million)
List of Figures
Figure 1 Dengue vaccine market segmentation
Figure 2 Market research process
Figure 3 Data triangulation techniques
Figure 4 Primary research pattern
Figure 5 Market research approaches
Figure 6 Value-chain-based sizing & forecasting
Figure 7 Market formulation & validation
Figure 8 Market snapshot
Figure 9 Therapeutic approach and product outlook (USD Million)
Figure 10 Competitive landscape
Figure 11 Dengue vaccine market dynamics
Figure 12 Dengue vaccine market: Porter’s five forces analysis
Figure 13 Dengue vaccine market: PESTLE analysis
Figure 14 Product market, 2021-2033 (USD Million)
Figure 15 Dengvaxia market, 2021-2033 (USD Million)
Figure 16 Qdenga market, 2021-2033 (USD Million)
Figure 17 Others market, 2021-2033 (USD Million)
Figure 18 End User market, 2021-2033 (USD Million)
Figure 19 Government & Public Health Agencies market, 2021-2033 (USD Million)
Figure 20 Hospitals & Specialty Clinics market, 2021-2033 (USD Million)
Figure 21 Others market, 2021-2033 (USD Million)
Figure 22 Dengue vaccine market revenue, by region
Figure 23 Regional marketplace: Key takeaways
Figure 24 North America dengue vaccine market, 2021-2033 (USD Million)
Figure 25 U.S. country dynamics
Figure 26 U.S. dengue vaccine market, 2021-2033 (USD Million)
Figure 27 Canada country dynamics
Figure 28 Canada dengue vaccine market, 2021-2033 (USD Million)
Figure 29 Mexico country dynamics
Figure 30 Mexico dengue vaccine market, 2021-2033 (USD Million)
Figure 31 Europe dengue vaccine market, 2021-2033 (USD Million)
Figure 32 UK country dynamics
Figure 33 UK dengue vaccine market, 2021-2033 (USD Million)
Figure 34 Germany country dynamics
Figure 35 Germany dengue vaccine market, 2021-2033 (USD Million)
Figure 36 France country dynamics
Figure 37 France dengue vaccine market, 2021-2033 (USD Million)
Figure 38 Italy country dynamics
Figure 39 Italy dengue vaccine market, 2021-2033 (USD Million)
Figure 40 Spain country dynamics
Figure 41 Spain dengue vaccine market, 2021-2033 (USD Million)
Figure 42 Norway country dynamics
Figure 43 Norway dengue vaccine market, 2021-2033 (USD Million)
Figure 44 Sweden country dynamics
Figure 45 Sweden dengue vaccine market, 2021-2033 (USD Million)
Figure 46 Denmark country dynamics
Figure 47 Denmark dengue vaccine market, 2021-2033 (USD Million)
Figure 48 Asia-Pacific dengue vaccine market, 2021-2033 (USD Million)
Figure 49 Japan country dynamics
Figure 50 Japan dengue vaccine market, 2021-2033 (USD Million)
Figure 51 China country dynamics
Figure 52 China dengue vaccine market, 2021-2033 (USD Million)
Figure 53 India country dynamics
Figure 54 India dengue vaccine market, 2021-2033 (USD Million)
Figure 55 Australia country dynamics
Figure 56 Australia dengue vaccine market, 2021-2033 (USD Million)
Figure 57 South Korea country dynamics
Figure 58 South Korea dengue vaccine market, 2021-2033 (USD Million)
Figure 59 Thailand country dynamics
Figure 60 Thailand dengue vaccine market, 2021-2033 (USD Million)
Figure 61 Latin America dengue vaccine market, 2021-2033 (USD Million)
Figure 62 Brazil country dynamics
Figure 63 Brazil dengue vaccine market, 2021-2033 (USD Million)
Figure 64 Argentina country dynamics
Figure 65 Argentina dengue vaccine market, 2021-2033 (USD Million)
Figure 66 MEA dengue vaccine market, 2021-2033 (USD Million)
Figure 67 South Africa country dynamics
Figure 68 South Africa dengue vaccine market, 2021-2033 (USD Million)
Figure 69 Saudi Arabia country dynamics
Figure 70 Saudi Arabia dengue vaccine market, 2021-2033 (USD Million)
Figure 71 UAE country dynamics
Figure 72 UAE dengue vaccine market, 2021-2033 (USD Million)
Figure 73 Kuwait country dynamics
Figure 74 Kuwait dengue vaccine market, 2021-2033 (USD Million)
Figure 75 Company categorization
Figure 76 Company market position analysis
Figure 77 Strategic framework

Companies Mentioned

The leading players profiled in this Dengue Vaccine market report include:
  • anofi
  • akeda Pharmaceutical Company Limited

Table Information

Report AttributeDetails
No. of Pages150
PublishedSeptember 2025
Forecast Period2025 - 2033
Estimated Market Value ( USD ) in 2025 $ 578.48 Million
Forecasted Market Value ( USD ) by 2033 $ 1610 Million
Compound Annual Growth Rate13.7%
Regions CoveredGlobal
No. of Companies Mentioned3

Related Topics

Related Reports

Dengue Vaccine Market Opportunities and Strategies to 2034 - Product Image

Dengue Vaccine Market Opportunities and Strategies to 2034

  • Report
  • 294 Pages
  • Global
From
Dengue Vaccine Market - Global Forecast 2025-2030 - Product Image

Dengue Vaccine Market - Global Forecast 2025-2030

  • Report
  • 198 Pages
  • Global
From
Dengue Vaccine Market by Vaccine Type, End User, Age Group, Vaccine Development Stage, Distribution Channel, Route of Administration, Technology, Patient Type - Global Forecast 2025-2030 - Product Image

Dengue Vaccine Market by Vaccine Type, End User, Age Group, Vaccine Development Stage, Distribution Channel, Route of Administration, Technology, Patient Type - Global Forecast 2025-2030

  • Report
  • 182 Pages
From
Vaccine Market Report by Technology, Patient Type, Indication, Route of Administration, Product Type, Treatment Type, End User, Distribution Channel, and Region 2025-2033 - Product Image

Vaccine Market Report by Technology, Patient Type, Indication, Route of Administration, Product Type, Treatment Type, End User, Distribution Channel, and Region 2025-2033

  • Report
  • 144 Pages
  • Global
From
Dengue Vaccine Global Market Report 2025 - Product Image

Dengue Vaccine Global Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.